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SUMMARY
Infection of wild animals by bovine tuberculosis (bTB) is raising concern worldwide. This article
reviews the current epidemiological situation, risk of emergence and control options at the
wildlife–livestock–human interface in sub-Saharan Africa. In livestock, bTB has been conﬁrmed
in the majority of countries from all parts of the continent. Wildlife infection is conﬁrmed in
seven countries from southern and eastern Africa, apparently spreading in the southern Africa
region. Mycobacterium bovis has been isolated from 17 wild mammal species, although only four
are suspected to play a role as maintenance host. Zoonotic risks are a concern, but no direct
spillover from wildlife to humans has been documented, and no case of bTB spillback from
wildlife to livestock has been conﬁrmed. In this paper we assess the main risk factors of bTB
spillover at the wildlife–livestock–human interface and suggest several research themes which
could improve the control of the disease in the African context.
Key words: Host (in infections), infectious disease epidemiology, spread of disease, tuberculosis
(TB), zoonoses.
INTRODUCTION
Infection of wild animals by bovine tuberculosis
(bTB), caused by Mycobacterium bovis, is raising con-
cern worldwide. The pathogen has been demonstrated
to infect a large number of free-ranging mammals
across different ecosystems, often characterized by
relatively moist conditions, such as North American
forests [1], insular ecosystems in the Paciﬁc [2] and
Great Britain [3], but also including drier ecosystems
such as the Iberian peninsula [4] and semi-arid savan-
nahs in Africa [5]. The importance of bTB infection in
wild animals relates to four aspects: (i) conservation
issues, as the disease may negatively impact on wild
mammal populations, including endangered species,
(ii) impact on livestock productions, as some wild
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species can maintain TB and act as a reservoir of the
pathogen for livestock, (iii) impact on public health,
with wildlife acting as a reservoir of infection either
directly or through livestock and (iv) economic
impacts on private game ranchers. So far, more than
60 wild mammal species worldwide have been
shown to be infected with M. bovis [6, 7], although
only a few have been demonstrated to play the
role of maintenance hosts. The best known examples
of the important constraint that wild free-ranging
hosts may represent for eradication of bTB are
the European badger (Meles meles) in the UK and
the Republic of Ireland [8, 9] and the possum
(Trichosurus vulpecula) in New Zealand [10, 11].
The ﬁrst reported diagnosis of M. bovis infection in
African free-ranging wild mammals was during the
1920s [12, 13], followed by the conﬁrmation of the
African buffalo (Syncerus caffer), as a maintenance
host during the late 1990s [14]. But it is unclear
when African wildlife ﬁrst became exposed to the
pathogen. Until recently it was believed that the origin
of bTB in Africa was associated with the importation
of infected cattle mainly from Europe and other con-
tinents, essentially during the past three centuries.
New studies have revealed the existence of at least
three clonal complexes ofM. bovis which each appears
to occur predominantly or exclusively in a geographi-
cally localized region of the world. The presence of
M. bovis strains belonging to the European 1 clonal
complex in South Africa, Tanzania and Zambia may
therefore indeed be explained by historical livestock
trade links between the UK and these African
countries [15]. Two additional clonal complexes,
African 1 [16] and African 2 [17], have been detected
in several countries in West-central and East Africa,
respectively, but very rarely outside Africa. The origin
of these twoM. bovis complexes is unknown and there
is a possibility that their progenitors evolved in cattle
in Africa any time between the appearance of classic
M. bovis over 2000 years ago [18, 19] and colonial
times [20]. Given current knowledge we cannot
exclude the possibility that the exotic status of bTB
in the indigenous African cattle population may
have to be re-considered, at least in some subpopu-
lations. It is therefore not possible to place the ﬁrst
M. bovis exposure of immunologically naive free-
ranging African wildlife populations within a deﬁned
time period, but it was likely sporadic in nature with
little or no chance of co-evolution [21]. Given the
exceptional diversity of African wild mammal species,
especially ruminants, presumed to be immunologically
naive to the infection, the disease might spillover to
wild African species, especially those that are taxono-
mically related to the domestic bovid reservoir host.
Livestock and wildlife have co-existed for at least
6500 years in Africa [22] especially in arid and semi-
arid lands, often sharing the same spaces and
resources [23]. However, wildlife–livestock–human
interfaces in Africa have been signiﬁcantly altered
during recent decades, with increasing encroachment
of human activities into wildlife habitats due to global
(e.g. human population demography, increased move-
ments of people and products) and regional (e.g.
development of Transfrontier Conservation Areas in
Southern Africa [24, 25]) dynamics. These changes
in the nature, frequency and intensity of wildlife–
livestock–human interactions may provide opportu-
nities for pathogen spillover and spillback [26].
Zoonotic risks due to M. bovis in Africa have been a
concern for more than 15 years [27]. Because
African countries often lack the resources to ad-
equately control bTB, and because there are numerous
populations living at wildlife–livestock–human inter-
faces, bTB represents a signiﬁcant risk for veterinary
and public health, and for conservation in Africa
[28, 29], if indeed the disease does spillback from
wildlife to livestock under African conditions.
In this paper, we review existing and recent infor-
mation on emerging bTB in wildlife in Africa, with
emphasis on the epidemiology and control of the dis-
ease at the wildlife–livestock–human interface. Based
on ofﬁcial records and published information, we
ﬁrst compare the current situations and management
of bTB in the different African subregions, illustrated
by several well documented case studies. We then
assess the drivers of bTB infection in wildlife and
identify the main factors likely to increase the risk of
transmission to livestock (‘livestock’ in this review
refers to all domesticated hoofstock species used for
human consumption, ﬁbre, draught, etc.) and to
human populations. We conclude by identifying the
main knowledge gaps and technical limitations, and
suggest several areas that should be targeted by
scientiﬁc research in order to improve bTB control
in the African context.
REGIONAL CONTEXTS FOR bTB
IN WILDLIFE IN AFRICA
Overview
According to the World Animal Health Information
databases collating reports of member states regarding
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outbreaks of transboundary animal diseases to the
Ofﬁce International des Epizooties (OIE) [30, 31],
during the period 1996–2011 the majority of
African countries (38/54) reported bTB in livestock
(infection or clinical disease), with an additional four
countries reporting suspected infection, while only
four countries that implemented general or targeted
surveillance reported the absence of the disease
(Fig. 1a). During the same period, bTB (clinical
cases) in wildlife were conﬁrmed in only 6/54
countries, all located in southern and eastern Africa
(Fig. 1b), with an additional ﬁve countries reporting
suspected cases, while 11 countries that implemented
general or targeted surveillance reported absence
of the disease, and 33 African countries indicated un-
availability of data regarding bTB in wildlife.
Bovine TB is a legally notiﬁable or controlled dis-
ease in livestock for several African countries, but
the information regarding bTB reports in wildlife
should be treated cautiously owing mainly to the
absence of simple and reliable diagnostic tests, and
because the veterinary services of most countries
lack the ﬁnancial and human resources to carry out
disease surveillance in wildlife. Nevertheless, pub-
lished information seems to indicate that bTB is prob-
ably widespread in livestock at the continental level
[32, 33], whereas bTB infection of wildlife has only
been conﬁrmed in few countries of southern and
eastern Africa [13, 21, 34].
Southern Africa
In southern Africa, bTB in free-ranging wildlife has
been conﬁrmed in South Africa [12, 35], Zambia [36]
and Zimbabwe [37], while the presence of the infection
has been suspected in African buffalo in Botswana
[38] although not conﬁrmed using gold standard
techniques. Furthermore, in Botswana, Alexander
et al. [39] reported the emergence of M. mungi, a
new member of theM. tuberculosis complex in banded
mongooses (Mungos mungo). In South Africa, bTB
was ﬁrst diagnosed in greater kudu (Tragelaphus
strepsiceros), and small antelopes in 1929 in the
Eastern Cape of South Africa [12]. In 1972, M. bovis
infection was reported in Kafue lechwe antelopes
(Kobus leche kafuensis), in the Lochinvar Game
Reserve in Zambia [34], followed by the isolation of
the pathogen from African buffalo in Gonarezhou
National Park (GNP) in Zimbabwe in 2008 [37].
The introduction of bTB into these wildlife popu-
lations has been largely ascribed to spillover from
domestic cattle [36, 40], with the exception of
GNP where buffalo-to-buffalo transmission from the
Kruger National Park (KNP) has been suggested
[37]. The establishment of bTB in a free-ranging eco-
system requires that the infection is maintained by at
least one wildlife reservoir which serves as source of
infection to a range of spillover hosts. Maintenance
host status has been shown for buffalo [14, 41] and
lechwe, and suggested for greater kudu [35, 40] and
possibly common warthog (Phacochoerus africanus
[42]). Lions also became infected in KNP, although
there is no evidence that they infect other species
and could therefore be considered dead-end hosts
(D. Keet, personal communication, 2012).
Transmission to wild spillover species may occur in
different ways, including aerosol, ingestion and percu-
taneous. However, the exact mode of transmission,
especially between ungulates remains poorly under-
stood. Apart from direct transmission, which requires
close contact between species, indirect transmission
via environmental contamination is a possibility,
although it has not been conclusively proven in
Africa (see [43, 44]). In Zambia, it has been postulated
that yearly seasonal ﬂoods play a role in the environ-
mental propagation and dissemination of microorgan-
isms (a point which needs further study and
elaboration), while overcrowding of animals during
lekking (mating season) with extra-large assemblages
at watering points enhances the direct animal-
to-animal transmission due to the contagious nature
of the disease [36]. Environmental transmission of
bTB could occur at locations where domestic and
wild animals congregate to rest, drink or feed and is
supported by the pathogen’s ability to survive in the
environment of KNP for between 5 days and 6
weeks, depending on temperature and moisture [45].
In addition, the gregarious nature of most wild bovids
with higher herd densities observed in drier seasons
is thought to facilitate intraspecies transmission of
M. bovis among wild ungulates.
In southern Africa, the interface between wildlife
and domestic livestock is often deﬁned by a game
deterrent fence, restricting movement and minimizing
contacts (for review see [46]), thus reducing the risk
of M. bovis transmission. There are, however, some
potentially infected species such as greater kudu and
common warthog, which are capable of crossing
these man-made barriers, and whose role in M. bovis
transmission at the interface remains to be quantiﬁed.
In addition, the boundaries of several conservation
areas in the region are either unfenced or very
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permeable to animal movements in both directions
because they have been damaged and/or are not
adequately maintained. Contacts between wildlife res-
ervoirs and livestock populations living at the per-
iphery of transfrontier conservation areas in southern
Africa, do occur and occasionally result in the trans-
mission of wildlife-borne diseases such as corridor dis-
ease or foot-and-mouth disease (e.g. [25, 47]). Thus,
there is a risk of bTB spillover from wildlife to live-
stock, and vice versa, although the environmental
pathways and frequency need to be determined.
Hence, measures to mitigate against such transmission
events may be required in order to protect local popu-
lations and their livestock living at the periphery of
transfrontier conservation in the southern African
region.
East Africa
Eastern Africa (see Fig. 1b) comprises a diversity of
countries and ecological zones, but is primarily a
moist to dry savannah ecosystem. Agriculture and
settlement have encroached on the dry grasslands,
where most livestock occur, putting considerable
pressure on the resilience of these biological com-
munities and land degradation is increasing as a
result [48]. In many of the low rainfall zones the live-
stock and wildlife share the same space, usually at
different times, which reduces the chance of direct
physical contact. Here, overall densities of wildlife
and livestock are relatively low, except in Ethiopia
where cattle densities are locally very high, and infec-
tious diseases tend towards endemicity. In some cul-
tures large cattle aggregations occur seasonally (e.g.
southern Sudan), and wildlife can locally reach high
densities where mass migrations still occur (e.g.
southern Sudan and in the Greater Serengeti-Mara
ecosystem of Kenya and Tanzania). These conditions
create frequent, even if indirect, contacts possibly
leading to disease spread and pathogen spillover
between species. There are few wildlife populations
which are fenced or artiﬁcially supplemented, leading
to high densities, but also mostly preventing contact
between wildlife and livestock. Eastern Africa con-
tains >50% of the total African livestock population.
Wildlife–livestock interactions occur at low frequency
and predominantly at unfenced areas. Most contacts
are indirect through the environment, at water points
and key forage resource areas, and are seasonally
related.
bTB in cattle
(a) (b)
Absence
Clinical
Infection
No data
Suspected
bTB in wildlife
Absence
Clinical
No data
Suspected
Fig. 1. Distribution map of bovine tuberculosis in Africa during 1996–2011 (large grey lines indicate the African
subregions as referred to in the text: West, Central, East and Southern Africa). (a) Cattle status at country level;
(b) wildlife status at country level. Asterisk (*) indicates countries (i.e. Botswana, Ethiopia, Kenya, Zimbabwe) where
suspected and conﬁrmed cases have been detected but not yet reported to OIE [37, 38, 50, 59, 60]. No additional
information (e.g. species) was available for suspected cases reported in wildlife for Niger, Equatorial Guinea and Guinea–
Bissau and conﬁrmed cases in wildlife in Mozambique. Data compiled from World Animal Health Information
databases/OIE [30, 31, 42] and [37, 38, 50, 59, 60].
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In the East African region, the evidence generally
suggests low prevalence of bTB in both wild [49, 50]
and domestic animals, with notable exceptions in
intensive husbandry systems (dairy) in some countries
such as Ethiopia, Uganda and Tanzania [51, 52] and
in pastoral systems in Uganda [53, 54]. The spillover
of bTB into humans in the region is poorly document-
ed [28], and Ugandan studies report an above global
average of ∼3% of human TB infection [54–56]. In
Ethiopia, despite the very high prevalence of extra-
pulmonary TB (EPBT) in humans, which is suggestive
of bTB infection, M. bovis was only isolated in 4/964
EPTB patients [52, 57]. Three out of 173 pulmonary
TB patients were M. bovis positive, and none of the
suspected lymphadenitis TB cases were positive in
another study among pastoralists in close physical
contact with livestock in south-east Ethiopia [58].
The disease is not a high priority for veterinary ser-
vices, except in the dairy sector, but data is lacking.
Historically, bTB has been a concern in Queen
Elizabeth National Park in Uganda [13], affecting a
range of wildlife species, with buffalo as a main-
tenance host. Recently bTB has caused detectable
mortality in kob (Kobus kob thomasi): 12 deaths sus-
pected to be due to bTB were reported in one locality,
and a further eight noticeably sick kobs were observed
and sampled over a period of 1 month from the same
population (P. Atemnedi, personal communication,
2011). Overall, the decline in ungulate populations
susceptible to bTB in the park is of concern, but the
contribution of disease to this trend or the drivers
for this are not known. Lion populations have also
declined (R. Bengis, personal communication, 2012)
but underlying causes (possibly disease or poaching)
have not been conclusively determined. Bovine TB
infection of buffalo and baboons has also been
conﬁrmed in Kenya [59, 60] and several wildlife
species have been found positive to serological rapid
tests in Ethiopia [50].
Central Africa
Boukary et al. [33] recently reviewed bTB studies in
domestic stocks in sub-Saharan Africa. Only seven
studies were related to bTB in livestock in Central
African countries, and the reported prevalence in
individual cattle ranged from 0·2% to 19·9% depend-
ing on the surveillance method adopted. The results
also depended on the age of the animals tested and
the type of production system considered, and on
the breed of cattle tested [61–63]. No published
information is available, to our knowledge, on bTB
in wildlife populations, and according to the OIE
database [30] only one ‘suspected’ bTB case in wildlife
was reported (in Equatorial Guinea) for the period
2007–2012.
Wild ungulates (including African buffalo) still per-
sist mainly in savannah ecosystems of southern Chad,
North Cameroon and the Republic of Central Africa,
and these largely decimated populations may be
exposed to bTB spillover from livestock. In forest
ecosystems, no study has been published on wildlife–
livestock interactions, especially between forest buf-
falo and cattle. Wildlife–livestock interactions may
be expected to be less frequent than in other parts of
the continent because densities of both livestock
and wildlife are lower and access to water usually
does not represent a limiting factor in these forest
ecosystems.
West Africa
Very little data has been published on bTB in wildlife
for West African countries (Fig. 1b). According to the
OIE database [30] only one ‘suspected’ bTB case
in wildlife was declared (in Niger) for the period
2007–2012. For livestock populations, the studies
that have estimated bTB prevalence in West Africa
revealed signiﬁcant variations according to the areas
and the production system considered [33, 64–66].
Low bTB prevalence was estimated in the Torodi
region of Niger (0·8% comparative intra-dermal skin
test positive [67]) and at Bamako’s abattoir in Mali
(1·8% with symptomatic gross lesions [68]). The
highest bTB prevalence in cattle was found in peri-
urban areas, in Ghana (13·8% comparative intra-
dermal skin test positive [69]) and in Mali (Bamako,
19% prevalence comparative intra-dermal skin test
positive [70]). The economic loss incurred by cattle
dealers due to bTB infection in cattle was estimated
at US$1 million in Togo in 1985, based on the meat
condemned at abattoirs because of the presence of
bTB lesions [71].
In West Africa, bTB thus appears to infect livestock
populations with a prevalence similar to other African
regions depending on the type of livestock production
system (i.e. higher in peri-urban vs. extensive systems
[67]). In addition, as for Central Africa, no reliable
data is available regarding wildlife. This may reﬂect
the absence of the disease in wildlife or it may be
due to the absence of appropriate surveys to detect it.
The abundance and distribution of most wildlife
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populations have markedly decreased in West Africa
during recent decades [72] due to over-harvesting of
wildlife and increasing human populations in the per-
iphery of protected areas [73]. For example, African
buffalo populations only persist in a handful of pro-
tected areas, where buffalo–cattle interactions appear
to be very infrequent [72]. The small size of remaining
wildlife populations and their reduced distributions
suggest that they are unlikely to act as a maintenance
host or signiﬁcant sources of bTB for cattle. In West
Africa, bTB seems to be widespread and poorly con-
trolled in cattle populations, and there is a risk that
bTB could spillover to naive and locally endangered
wildlife populations.
EPIDEMIOLOGY OF bTB AT AFRICAN
WILDLIFE–LIVESTOCK–HUMAN
INTERFACES
Conceptual model of bTB transmission at the
wildlife–livestock–human interface
A disease reservoir may consist in a maintenance
population or community (i.e. with more than one
species involved) within which a given pathogen can
be maintained and which acts as a potential source
of infection for a target species [74]. In the case of
bTB in Africa, maintenance populations have been
identiﬁed as cattle, lechwe and buffalo. The existence
of a maintenance community remains unknown. The
role played by other wild ungulate species, such as
the greater kudu and the common warthog, is still
debated although in theory, they could connect res-
ervoir (e.g. buffalo) and target (e.g. naive cattle) popu-
lations, and so contribute to the maintenance
community of bTB. Similarly, the maintenance com-
munity created by sympatric cattle and buffalo popu-
lations in frequent contacts may allow bTB spillover
or spillback, and could act as a source of bTB for
other target populations.
Within this maintenance community framework,
bTB epidemiology may be represented as a dynamic
multi-host system with three main ‘compartments’,
namely wildlife, livestock and humans (Fig. 2).
Bovine TB infections may be maintained (indepen-
dently or not) within livestock populations and within
wildlife populations, whereas human infections result
from pathogen spillover from animals [75], and very
Type of interface (fenced/unfenced,
permanent/seasonal, etc.)
Environmental conditions
(survival of bTB, water holes, grazing, etc.)
Density of wildlife
bTB in
Wildlife
bTB in
Humans
Human behaviour
(occupation, food habits, hunting, etc.)
bTB in
Livestock
Diversity of wildlife Cattle trade/import
Nomadic/sedentary
Existence/efficiency of
bTB control
Production system (dairy,
communal, etc.)
Connectivity/migration
of wildlife
Spillback
Spillover
Existence/efficiency of
bTB control
Fig. 2 [colour online]. Interspeciﬁc transmission of bovine tuberculosis (bTB) at wildlife–livestock–human interfaces in
Africa. Bovine TB can be maintained in livestock (bTB in livestock) and in wildlife (bTB in wildlife), promoted by factors
indicated in italics with a grey arrow (e.g. diversity of wildlife, production system). Risks of bTB spillover from livestock
to wildlife or humans, and spillback from wildlife to livestock, are indicated in boxes with black arrows (e.g. environmental
conditions, human behaviour, etc.).
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rarely from human-to-human transmission [76]. In
the following sections we review the main risk factors
of bTB infections within the livestock and wildlife
compartments, and identify the main drivers of inter-
speciﬁc transmission of bTB (‘spillover’ and ‘spillback’
[26]; Fig. 2) at wildlife–livestock–human interfaces in
Africa.
Livestock as a source of bTB: spillover to wildlife
and humans
The main bTB risk factors in African cattle popu-
lations (see Fig. 2; adapted from [33, 53, 77–81])
include the type of production system (intensive,
dairy farms, use of upgraded B. taurus breeds), animal
movements (herds importing animals, transhumance)
and absence or inefﬁciency of bTB surveillance and
control.
Several studies have analysed bTB risks of trans-
mission between livestock and humans [58, 67, 75,
80, 82], identifying husbandry practices (housing, mix-
ing cattle herds with other small ruminants), food pre-
ferences (consumption of raw or soured milk) and
overall health and hygienic conditions (HIV) as the
main risk factors for humans (Fig. 2). The role of live-
stock as a source of infection for humans has been
relatively well documented and established in Africa
[51, 58, 82]. It should be noted that these studies rarely
determined with certainty (i.e. using molecular tech-
niques) the animal source and the routes of trans-
mission [54, 83–85]. In addition, it has been shown
that several livestock species other than cattle may
be infected by M. bovis in African conditions (e.g.
camels in Kenya and Ethiopia [86, 87]) although
apparently with lower prevalence than cattle (e.g.
camels and goats in pastoralist herds in Ethiopia
[58]), but the epidemiological role that they might
play in bTB multispecies systems remains unexplored.
Although bTB is currently established in several
wildlife populations from several sub-Saharan African
countries, the introduction of M. bovis into a com-
munity of free-ranging wild animals has been best
documented in KNP, South Africa. The disease was
ﬁrst diagnosed in the early 1990s in the African
buffalo population in the southern part of the park [5].
The primary source of the pathogen is believed to
have been an infected cattle population in the
Komatipoort/Malelane region [88], located south of
the Crocodile River, which forms the southern border
of the park. Direct (or indirect) spillover from cattle
to buffalo must have occurred in or prior to 1960
according to phylogenetic analyses of isolated strains.
The genetic characterization of bTB strains isolated
from wildlife in KNP indicated a common source in
the African buffalo, followed by clonal expansion of
the strain [40]. We have no indication of the route of
transmission for this initial spillover of bTB from
cattle to buffalo, but it is believed that they may
have entered into close contact, sharing water and
grazing resources at this unfenced interface. It is also
speculated that only a limited number of transmission
events between cattle and buffalo have occurred, as
the disease took a long time to spread to other buffalo
herds within the park.
Although detailed documentation of transmission
risks only exists for South Africa and Uganda, we
suggest that the main risk factors potentially leading
to bTB spillover (Fig. 2) may be related to: (i) the
type of wildlife–-livestock interface (absence of physi-
cal separation such as fence, allowing for repeated and
prolonged direct or indirect contacts); (ii) the environ-
mental conditions, leading to competition/sharing
of common resources (water and grazing) and also
compatible with the persistence of M. bovis in the
environment.
Wildlife as a source of bTB: spillback to livestock
or spillover to humans
So far, two free-ranging mammal species have been
demonstrated to play a role as maintenance hosts
in natural conditions, the African buffalo in KNP,
South Africa [14] and the lechwe in the Kafue basin,
Zambia [34, 36]. Two other species, greater kudu
and common warthog, are also considered as poten-
tial maintenance hosts [42], but no published data
exist to conﬁrm this. Since its introduction during
the 1960s, bTB has increased its host range by infect-
ing at least 14 species of wild mammals within the
boundaries of the Greater KNP Complex [35] includ-
ing a sporadic case in a bushbuck (Tragelaphus
scriptus) [42]. The epidemiology of bTB in African
wildlife has been described as a multi-species host–
pathogen system [47, 88]. Although many of the
mechanisms involved remain uncertain, the main
risk factors leading to introduction and maintenance
of the infection in a wildlife population (Fig. 2) are
probably linked with species diversity (maintenance
or spillover hosts), social behaviour of wildlife hosts,
wildlife densities (threshold population/community
densities), movements of animal populations (poss-
ible introduction through migratory individuals,
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conﬁnement), and absence or inefﬁciency of wildlife
bTB surveillance and control.
Few studies in Africa have speciﬁcally investigated
the transmission of bTB from wildlife to livestock
(spillback; Fig. 2). Although other diseases have
been demonstrated to occasionally spread from KNP
wildlife to neighbouring cattle populations (e.g. [25]),
so far no suspected cases of bTB spillback from wild-
life to cattle living in contact with the KNP fence have
been conﬁrmed using gold-standard techniques. In
2008, the main bTB strain circulating in KNP buffalo
populations was demonstrated to have spread to
the GNP buffalo population in Zimbabwe [37].
However, several surveys carried out in the surround-
ing communal lands indicated that bTB has not
infected the cattle population [89]. Factors associated
with bTB spillover from livestock to wildlife (see
above [90]) should also inﬂuence bTB spillback from
wildlife to livestock (Fig. 2). The main risk factors
are thus linked with: (i) the type of interface (fence,
herding practices) and the distribution of resources
(water and grazing), which directly inﬂuence contact
patterns between livestock and wildlife; (ii) the
environmental conditions, which directly inﬂuence
the persistence of bTB in the environment. It is there-
fore of paramount importance to further understand
the spatio-temporal overlap between buffalo and
cattle (and other reservoir hosts) [89].
Human infections withM. bovis from infected wild-
life, acquired through ingestion or aerosol exposure,
have been described only sporadically as an occu-
pational and recreational hazard, mainly for wildlife
veterinarians, hunters, taxidermists and people pre-
paring and consuming venison [91]. To our knowl-
edge, no cases have so far been described in Africa
ofM. bovis in people that are likely to have originated
from wildlife, although speciﬁc investigation has been
lacking at the wildlife–human interface, except in
KNP [92]. We assume that the zoonotic risks associ-
ated with wildlife bTB (Fig. 2) are similar to those
involved in bTB spillover from livestock, mainly
related to human behaviour and activities: occupation
(national park staff, veterinarians), dietary habits
(venison consumption) or leisure (hunting, ecotourism).
Ecology of bTB transmission in Africa: source or
sink in multi-host systems?
Transmission of M. bovis at wildlife–livestock–human
interfaces in sub-Saharan Africa is driven by bio-
logical, ecological and anthropological processes.
Spillover, and spillback, events between wildlife and
the two other compartments are probably relatively
rare in Africa, with the limited interfaces prevailing
in most African countries, but many aspects of this
complex system are not well understood.
It is often difﬁcult to accurately study the dynamics
of pathogen spread in bTB outbreaks in livestock due
to the implementation of control measures such as
test-and-slaughter. In wildlife populations, it is mostly
unknown when the pathogen was introduced and
the situation may be further complicated by mixed
and ongoing introductions from multiple sources.
However, the bTB epidemic in KNP offers a unique
opportunity to study the epidemiology of a single
strain of this multi-host pathogen in a multi-species
environment in the absence of human control inter-
ventions. Following its introduction into the naive
buffalo population of KNP, M. bovis spread mainly
between buffalo herds and spilled over into at least
13 other species [42], the true extent of which is
unknown as bTB monitoring and surveillance in wild-
life are most effective in the more visible species show-
ing signs of disease, and where active surveillance has
taken place (mainly in buffalo). Molecular analysis of
M. bovis isolates from affected herbivores, predators
and omnivores was able to provide evidence for direct
M. bovis transmission (e.g. between predator and
prey) but also for indirect transmission (e.g. between
buffalo and kudu [40]). Bovine TB epidemiology in
wildlife is thus a complex multi-host pathogen system
[88], partly driven by resource selection and spatial
ecology of wild herbivores sharing common resources
and by predator–prey interactions.
As bTB can be transmitted between (wild and dom-
estic) hosts through indirect contact with the contami-
nated environment (e.g. grass, trees, water, faeces
[93]), there is also a possibility that contact patterns
between wildlife and livestock may result in direc-
tional bTB transmission, with spillback being pre-
vented or likely to occur with a lower probability
than spillover transmission. Cattle and buffalo may
share the same space and resources, but not at the
same time/season, and this temporal shift in use (e.g.
night/day, season) may result in different risks of
disease transmission through indirect contact if the
survival of the bacteria in the environment differs
according to time/season. In southern Africa, for
instance, cattle are commonly conﬁned in kraals at
night and driven during the day by herders who decide
to a large extent in which area cattle herds will graze
and at which water hole they will drink, while buffalo
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roam freely. In addition, differential grazing behav-
iour between livestock and wildlife (e.g. avoidance of
sites contaminated by faeces or different preferences
for feeding patches) may also result in directional
bTB transmission. This could explain why the domi-
nant parental KNP strain has spread to buffalo popu-
lations within KNP and even to GNP in Zimbabwe,
while current evidence suggests that it has not spilled-
back to cattle populations adjacent to KNP or GNP.
Similarly, indirect buffalo–cattle contacts and active
test-slaughter control in the buffalo population of
Hluhluwe–Umfolozi National Park (South Africa)
could explain why bTB strains have spilled over
from cattle to buffalo, as indicated by molecular
analysis [36], while spillback from buffalo to cattle
or human populations has not been reported to date.
Currently, even in southern Africa, bTB spillback
from wildlife to livestock (and humans) has not been
conﬁrmed. But indirect contacts between cattle and
buffalo do occur at the periphery of several large con-
servation areas in southern Africa, where no efﬁcient
fences separate conservation areas from adjacent com-
munal lands. This could lead to a situation where
domestic and wildlife reservoirs co-exist, creating a
complex maintenance system that would be more difﬁ-
cult to control [74]. In addition, wild spillover hosts,
which are considered as unable to maintain bTB
infection alone, could play a crucial epidemiological
role as ‘bridge’ species, between the wild and dom-
estic compartments. For instance impala (Aepyceros
melampus), although rarely infected by bTB [42],
and greater kudu or common warthog (considered
as potential maintenance hosts [42]), are relatively
abundant at wildlife–livestock interfaces and relatively
tolerant of human activities. As these species use com-
mon water or food resources, they could potentially
transmit bTB infection in both directions, although
this has not been demonstrated so far.
MANAGEMENT AND CONTROL OF bTB
AT WILDLIFE–LIVESTOCK–HUMAN
INTERFACES
Why control bTB in wildlife?
Bovine TB is an alien disease in African wildlife
[21], and there are numerous reasons that could
justify implementing control measures in wildlife
populations: impacts on conservation objectives/
endangered species, tourism, wildlife trade, risk of
spillback to livestock and spillover to humans. As it
is a slow progressive and zoonotic disease, with lim-
ited tools for diagnosis and control, it makes sense
to act proactively to prevent it from entering wildlife
populations. Once M. bovis has been introduced in a
wildlife population, it is very difﬁcult to control the
disease [31, 90]. Consequently, every effort should
be made to protect wildlife populations that are
not infected, by reducing the risk of spillover from
livestock.
What are the control options for bTB in African wildlife
The KNP example does help in understanding the
complex environment in which we are trying to con-
trol the disease in wildlife populations. Due to the
expense and difﬁculty of diagnosing TB in wildlife
(non-validated tests and expense of immobilizing) it
is impossible to apply test-and-slaughter approaches
in large open ecosystems. In smaller parks like
Hluhluwe-Umfolozi where herds are in distinct
conﬁned areas, test-and-slaughter has been im-
plemented, resulting in a reduction of bTB incidence
in the buffalo population but not in the eradication
of the disease [94]. Although fences may have severe
negative ecological and socio-cultural impacts, they
keep buffalo and cattle separated most of the time,
which efﬁciently reduces the risks of disease spillover
[25]. However, when fences are damaged, buffalo
and/or cattle may cross the boundaries of the pro-
tected area, increasing these risks. In the far northern
region of KNP adjoining Mozambique and southern
GNP there are no fences and spatial overlap between
cattle and buffalo is a regular event. However, there is
ﬁeld evidence that buffalo and cattle do not mix
readily. This also applies to buffalo that leave the
fenced areas to the west of KNP, as most records of
escaped buffalo are in areas where there are no cattle,
pointing to possible active avoidance of close contact
(State Veterinary Skukuza, personal communication).
Lessons learned from past and current
measures/strategies
Once bTB was diagnosed in KNP in 1990, manage-
ment conducted regular surveys in buffalo herds
throughout the park. The disease was conﬁned to
the south of the park (south of the Sabie River) in
1992, but surveys carried out in 1994, 1996 and 1998
clearly demonstrated that the disease was spreading
northwards through inter-herd transmission. By 2005,
it had reached buffalo in the far northern part of the
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park (D. Keet, internal State Veterinary Report,
2005). In 2008, it was diagnosed in GNP in southern
Zimbabwe. Various control methods were discussed,
including culling all buffalo south of the Sabie River
and putting up a fence to the north of known bTB
herds. Even complete eradication of buffalo and
restocking was considered but the ecological impact
was considered more serious than the risk taken by
not being able to fully eradicate the disease. In the
last decade numerous studies have been conducted
to determine the longitudinal impact of bTB in buf-
falo and no population effect in buffalo [95]. A similar
study is now being conducted in lions in KNP [96].
Limited attention has been paid to the risk and inci-
dence of spillback of bTB from buffalo to livestock,
but bTB tests conducted in cattle to date to the west
of KNP and southern Zimbabwe [89] have failed to
conﬁrm bTB in the adjacent areas using gold-standard
techniques. Lessons learnt from the KNP example
showed that better surveillance in the 1950s to 1990s
could have resulted in earlier disease detection with
a possible test-and-slaughter control strategy. Once
bTB has established itself, more localized risk man-
agement is the most cost-effective way to prevent
spillover and spillback between wildlife and livestock.
Fencing would be the primary line of defence to curb
bTB spread. In the absence of fences, innovative ways
of keeping buffalo and cattle apart should be con-
sidered (e.g. herding and kraaling cattle, or manipu-
lation of water availability at the interface and
supervised visits to water holes). The effort and impact
of bTB control and risk management must also be
seen in the context of preventing other livestock-
related diseases from transmitting across the wild-
life–livestock interface.
When bTB management and control measures are
envisaged, it is important to consider deterministic
factors at play in the epidemiology of the disease.
Further, the choice of workable control measures
and strategies despite being limited for wildlife,
should take into account all key factors unique to
each different ecosystem. A number of factors have
been observed to be associated with bTB in cattle
herds [97]. Oloya and co-workers observed that bTB
was associated with different types of drinking water
sources [53]. The same study also indicated that risks
of bTB in cattle are linked to speciﬁc geographical
regions of production. This implies that bTB control
may thus vary according to prevailing ecological
conditions. Further, bTB has also been shown to
be associated with communal grazing, animal breed
and husbandry practices across most of the African
continent [97]. Similarly, studies have also shown
that herd size has an inﬂuence on the prevalence of
bTB [79, 98–100]. Taken together, these factors are
vital in formulating workable control strategies for
cattle bTB across African pastoral communities.
However, control measures such as the test-and-
slaughter schemes used to control bTB in cattle
populations are impractical in free-living wildlife
populations. Nevertheless, at the livestock–wildlife–
human interface more detailed studies are needed to
understand both key and proxy factors related to the
maintenance, spread and transmission of the disease
among susceptible hosts. Owing to the impracticality
of other control measures, the key factor at the live-
stock–wildlife–human interface area is to reduce or
to completely eliminate interspecies contact. Selective
cropping of old, debilitated animals can also be used
to remove what may be chronic shedders of the disease.
BCG vaccination in buffalo has been shown to provide
poor protection [93] and further work on approaches to
vaccination is required, including target species, age of
vaccinees and new vaccine formulations. BCG vacci-
nation of cattle populations living in contact with wild-
life could also be envisaged in order to prevent or
reduce the risks of bTB spillback and spillover, but
there is also a need to evaluate the efﬁciency of such
control strategies. However, given the lack of scientiﬁc
data and resources of most developing countries, the
use of vaccines is impracticable at the moment. A
more feasible option is the creation of double fences
or buffer zones (e.g. with limited and managed grazing
of livestock, with wildlife hunting activities), with a
zone where there is sufﬁcient distance to avoid environ-
mental contamination with M. bovis.
Perspectives for a one health approach
Studies on bTB in Africa have so far focused rather
narrowly, either on livestock, wildlife or human health
research in separate compartments. Systems-based
research involving both the animal and the public
health sector have rarely been undertaken [92].
Despite decades of research on bTB, there is still
very little information on the epidemiology of bTB
in Africa. Important knowledge gaps include the
strains involved in humans and animals in the same
areas, spillover and spillback dynamics, quantiﬁca-
tion of risk factors of disease transmission between
wildlife–livestock–humans, impact of bTB on ani-
mal health and animal productivity and livelihoods,
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impact on conservation and dynamics of wildlife
population. The absence of this information probably
reﬂects the apparently low incidence of bTB in
humans, and of bTB transmission between wildlife
and livestock, although this picture may change
given increasing overlap at the interface between
species in many parts of Africa. Due to the nature
of the disease (multi-host pathogen with impact on
humans, animals and ecosystem health), collaboration
between the public and animal health sectors, includ-
ing wildlife specialists, is important from a sanitary,
and probably also from an economic, point of view.
Integrated research is paramount to gain a better
understanding of the epidemiology of bTB at the
human–livestock–wildlife interface, to be able to
quantify the impact of the disease and to propose
adequate and sustainable control approaches.
CONCLUSIONS, KNOWLEDGE GAPS
AND THE WAY FORWARD
The information collated in this review conﬁrms that
bTB is widespread in livestock on the African conti-
nent [32], whereas bTB infection of wildlife, which
was historically limited to a few countries in southern
and eastern Africa (South Africa, Tanzania, Uganda,
Zambia) may be spreading in southern Africa
(Mozambique [30], Zimbabwe [37]). Although the
impact of bTB may be signiﬁcant in Africa, affecting
the economy, the ecosystem and human health [28],
wildlife TB is currently not considered a priority for
most African countries. M. bovis has been isolated
from a wide range of wild free-ranging mammals,
including maintenance hosts in natural conditions,
which will considerably complicate future bTB
control programmes [101], and possibly compromise
the chances of eradication in sub-Saharan African
countries. But to date, to our knowledge, no cases
have been documented in sub-Saharan Africa demon-
strating M. bovis spillback from infected wildlife to
cattle or spillover to human populations.
Currently, bTB in African wildlife south of the
Sahara is essentially a conservation issue, with social,
welfare and economic implications for the affected
areas/countries. Although the ecological impacts of
bTB on infected free-ranging populations is still not
clearly demonstrated (even for buffalo [102] or
lions [96]), there is concern in southern Africa that
transboundary animal diseases spread by wildlife,
and bTB in particular, may negatively impact on
economic activities and livelihoods of local people,
especially in the context of transfrontier conservation
areas initiatives [35]. In other parts of Africa, it is
likely that the risk of bTB transmission between wild-
life and livestock (and possibly humans) will increase
in the near future, with ever-increasing human
encroachment into wildlife habitats due to the demand
for grazing and cropping land, and possibly through
dissemination of bTB-positive upgraded livestock
into rural areas (e.g. dairy cattle breeds in Ethiopia).
This will have serious consequences for biodiversity
conservation, as bTB may potentially further threaten
several small and isolated wildlife populations (includ-
ing endangered species at a local or global scale), and
also potentially for veterinary and public health as the
wildlife reservoir will complicate future bTB control
or eradication programmes.
Several major knowledge and technical gaps must
be addressed before effective long-term control of
bTB at the wildlife–livestock–human interface in
Africa can be put in place. The ﬁrst gap in knowledge
relates to the absence of understanding of the role of
individual wildlife species/populations in the epidemi-
ology of bTB in complex multi-host systems [88].
This also applies to several livestock species other
than cattle, like goats and pigs, which can be infected
by bTB but for which no information is available on
the role they play in the epidemiology of the disease
in sub-Saharan African contexts. Despite recent con-
ceptual [103] and methodological (e.g. [104]) develop-
ments, there is a general lack of longitudinal data
(with the exception of South Africa). Longitudinal
surveys are needed in order to monitor the (temporal)
dynamics of the infection, and also to provide
M. bovis isolates from African wildlife populations.
These isolates are needed to elucidate the epidemi-
ological role of the various species and the relationship
between the wild and domestic host populations.
The second knowledge gap relates to the absence of
understanding of the ecological and anthropogenic
drivers of contacts between wildlife and livestock
(see [89]), and humans, potentially leading to bTB
transmission. Recent advances in telemetry have
improved our understanding of the movements of
free-ranging animals, but there is a need for multi-
disciplinary approaches bringing together ecology,
sociology and epidemiology in order to identify the
main drivers of contacts, and to investigate how the
manipulation of shared resources might mitigate
the risks of disease transmission. The third knowledge
gap concerns environmental source of M. bovis,
and the persistence of infectious material in various
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African ecosystems. Previous studies have given con-
trasting results [44, 45], and there is need for more
thorough investigations in the future, as the import-
ance of indirect transmission in the epidemiology of
bTB remains elusive.
Improving surveillance and control of bTB at
African wildlife–livestock–human interfaces also
requires accurate, affordable and reliable diagnostics,
as the performance of existing tests is unknown for
most wild African species. However, this technical
limitation will probably remain a major challenge
because the veterinary bTB diagnostic market is very
small, and virtually non-existent for (African) wildlife
[105]. In addition, new developments in the ﬁeld are
often not suitable for developing countries, either
because they require sophisticated laboratory infra-
structure and/or well-trained personnel [28]. In the
long term, the development of effective vaccines
could signiﬁcantly contribute to protecting targeted
wildlife populations and/or maintaining bTB preva-
lence below a threshold that would reduce the risk
of spillback to livestock. A BCG vaccine has shown
some promise in badgers in Europe [106]. BCG vac-
cine failed to protect African buffalo against bTB in
an initial study [107]. Nevertheless, the potential long-
term beneﬁt from reducing the infection pressure
through vaccination of maintenance hosts warrants
further investigation. BCG vaccination of cattle popu-
lations living in contact with wildlife could also be
envisaged in order to prevent or reduce the risks of
bTB spillback and spillover, but there is also a need
to evaluate the efﬁciency of such strategies.
From a wider mycobacterial perspective, we also
acknowledge that M. tuberculosis remains a greater
risk to African human populations than M. bovis. In
addition, there are several other animal diseases that
have more signiﬁcant direct or indirect detrimental
impacts on livestock at wildlife–livestock interfaces
in Africa (e.g. corridor disease and foot-and-mouth
disease). The effort and resource allocation required
to control the threat of bTB at the wildlife–livestock–
human interface should therefore be linked to other
critical transdisciplinary programmes aiming at im-
proving the health of humans and their livestock
and associated wildlife.
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